Delayed Prostate Cancer Therapy Frederick MD

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Dr.Elhamy Eskander
(301) 662-8477
501 W 7th St # 1
Frederick, MD
Gender
M
Education
Medical School: Univ Of Cairo, Fac Of Med, Cairo
Year of Graduation: 1979
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided by:
Paul Gregory Rausch, MD
(301) 662-8477
501 W 7th St Ste 1
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Southern Ca Sch Of Med, Los Angeles Ca 90033
Graduation Year: 1970

Data Provided by:
Brian O'Connor
(301) 662-8477
501 W 7th St
Frederick, MD
Specialty
Hematology / Oncology

Data Provided by:
Stephen Paul Creekmore, MD
Dtp Dctd Nci Frederick Cancer Rsch Fac
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, San Francisco Ca 94143
Graduation Year: 1976

Data Provided by:
Amr Zakaria Hegazi, MD
(301) 695-6777
46B Thomas Johnson Dr
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Ain Shams Univ, Fac Of Med, Abbasia, Cairo, Egypt (330-04 Pr 1/71)
Graduation Year: 1986

Data Provided by:
Paul Gregory Rausch
(301) 662-8477
501 W 7th St
Frederick, MD
Specialty
Hematology / Oncology

Data Provided by:
Jeremy Goodrich Perkins, MD
(202) 782-6751
5351 Partners Ct
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Uniformed Services Univ Of The Hlth Sci, Bethesda Md 20814
Graduation Year: 1997

Data Provided by:
Elhamy D Eskander, MD
(301) 662-8477
501 W 7th St
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Cairo, Fac Of Med, Cairo, Egypt (330-02 Prior 1/71)
Graduation Year: 1979

Data Provided by:
Erwood G Edwards, MD
PO Box 546
Walkersville, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1982

Data Provided by:
Amr Z Hegazi
(301) 695-6777
46b Thomas Johnson Dr
Frederick, MD
Specialty
Hematology, Hematology / Oncology, Medical Oncology

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com